Early Feasibility Study to Assess the Safety and Effectiveness of the OnePoint Dialysis CannulaTM as a Single-Site Vascular Access Device for Hemodialysis Procedures
NCT:NCT07599085 · NOT_YET_RECRUITING
廣告
NCT IDNCT07599085
狀態NOT_YET_RECRUITING
開始日期2026-08-01
SponsorEvolve Medicus, Inc. (INDUSTRY)
First posted
Last updated
簡要摘要
This is an early feasibility, pre-market, prospective, interventional, single-arm, non-randomized / open-label study intended to support a future pivotal IDE study for eventual FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。